HW
GILD icon

Hedeker Wealth’s Gilead Sciences GILD Stock Holding History

Hedeker Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-19,605
Closed -$1.17M – 90
2022
Q1 		$1.17M Buy
19,605
+4,723
+32% +$302K 0.35% 71
2021
Q4 		$1.08M Sell
14,882
-207
-1% -$14.3K 0.31% 71
2021
Q3 		$1.05M Buy
15,089
+1,584
+12% +$111K 0.33% 70
2021
Q2 		$929K Sell
13,505
-517
-4% -$34.5K 0.29% 68
2021
Q1 		$906K Sell
14,022
-111
-0.8% -$7.16K 0.32% 59
2020
Q4 		$823K Buy
14,133
+2,887
+26% +$174K 0.29% 60
2020
Q3 		$710K Sell
11,246
-628
-5% -$43.5K 0.34% 62
2020
Q2 		$913K Buy
+11,874
New +$910K 0.47% 54

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hedeker Wealth's GILD Position: Q2 2022 in Review

Hedeker Wealth sold out of Gilead Sciences (GILD) in Q2 2022, closing a stake of 19,605 shares — an estimated $1.17M sold.

Hedeker Wealth first reported a position in GILD in Q2 2020 and held it in 8 quarters. The position peaked at $1.17M in Q1 2022. 1,603 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

  • Hedeker Wealth reported no remaining Gilead Sciences position as of Q2 2022 after selling out during the quarter.
  • Hedeker Wealth sold 19,605 Gilead Sciences shares in Q2 2022, an estimated $1.17M.
  • Hedeker Wealth first reported a position in Gilead Sciences in Q2 2020 and held it in 8 quarters.
  • Hedeker Wealth's Gilead Sciences position peaked at $1.17M in Q1 2022.
  • 1,603 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Hedeker Wealth's 13F filing for Q2 2022, filed 28 Jul 2022.